Clover Health Investments, Corp. (NASDAQ:CLOV) Short Interest Update

Clover Health Investments, Corp. (NASDAQ:CLOVGet Free Report) was the recipient of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 45,330,000 shares, a decrease of 5.2% from the April 30th total of 47,810,000 shares. Based on an average daily trading volume, of 9,460,000 shares, the days-to-cover ratio is currently 4.8 days.

Clover Health Investments Stock Down 5.1 %

Clover Health Investments stock opened at $1.11 on Wednesday. The business has a fifty day moving average of $0.81 and a two-hundred day moving average of $0.89. The firm has a market cap of $551.05 million, a P/E ratio of -3.26 and a beta of 2.09. Clover Health Investments has a twelve month low of $0.61 and a twelve month high of $1.63.

Clover Health Investments (NASDAQ:CLOVGet Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.02. The business had revenue of $346.92 million for the quarter, compared to the consensus estimate of $316.10 million. Clover Health Investments had a negative return on equity of 48.07% and a negative net margin of 8.63%. Equities analysts expect that Clover Health Investments will post -0.21 earnings per share for the current year.

Insider Activity

In other news, Director Anna U. Loengard purchased 137,000 shares of the stock in a transaction that occurred on Thursday, March 14th. The stock was purchased at an average price of $0.73 per share, for a total transaction of $100,010.00. Following the completion of the acquisition, the director now owns 538,841 shares of the company’s stock, valued at $393,353.93. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 22.28% of the company’s stock.

Hedge Funds Weigh In On Clover Health Investments

Several hedge funds have recently made changes to their positions in the company. Jaffetilchin Investment Partners LLC increased its position in shares of Clover Health Investments by 30.2% in the 1st quarter. Jaffetilchin Investment Partners LLC now owns 49,741 shares of the company’s stock valued at $39,000 after acquiring an additional 11,550 shares during the period. Swiss National Bank grew its position in Clover Health Investments by 1.6% during the 3rd quarter. Swiss National Bank now owns 782,200 shares of the company’s stock worth $845,000 after purchasing an additional 12,400 shares during the period. Connor Clark & Lunn Investment Management Ltd. boosted its stake in shares of Clover Health Investments by 2.6% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 813,695 shares of the company’s stock worth $879,000 after acquiring an additional 20,813 shares in the last quarter. Vanguard Personalized Indexing Management LLC purchased a new stake in shares of Clover Health Investments during the 3rd quarter worth about $25,000. Finally, Allspring Global Investments Holdings LLC purchased a new stake in shares of Clover Health Investments during the 3rd quarter worth about $26,000. 19.77% of the stock is owned by institutional investors and hedge funds.

Clover Health Investments Company Profile

(Get Free Report)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.

Recommended Stories

Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.